Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesDeterminant Factors of Osteoporosis Patients' Reported Therapeutic Adherence to Calcium and/or Vitamin D Supplements: A Cross-Sectional, Observational Study of Postmenopausal Women
Drugs & Aging, 09/21/09
Sanfelix–Genoves J et al. – Only one in two postmenopausal women with osteoporosis who take calcium and/or vitamin D have good self–reported therapeutic adherence to this treatment. Determinant factors of adherence to calcium and/or vitamin D treatment were patient's attitude to the treatment, tolerability problems with the treatment and number of concurrent treatments.
Methods- A cross–sectional, observational study was conducted in a sample of postmenopausal women receiving pharmaceutical treatment for osteoporosis with vitamin D and/or calcium.
- Sociodemographic, general and osteoporosis–related data were collected.
- Patient's perceptions of the adverse effects of treatment, their knowledge of osteoporosis (Batalla test), their attitude towards treatment (Morisky–Green test) and their self–reported therapeutic adherence (Haynes–Sackett test) were assessed.
- Of 630 women evaluated, 36.2% had problems with treatment tolerability, 63.5% had good knowledge of osteoporosis, 20.5% had a good attitude to treatment and 50.0% had good self–reported adherence to treatment.
- Patients in the poor adherence group had higher mean body mass index, more concurrent pathologies, more tolerability problems and worse attitude to treatment.
- The multivariate model showed a positive relationship between therapeutic adherence and good attitude to treatment, not having tolerability problems and no polymedication.
Related Articles
Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis
International Journal of Women's Health, 11/18/09
Relevance Score: 92%
Progress in osteoporosis and fracture prevention: focus on postmenopausal women
Arthritis Research & Therapy, 10/28/09
Relevance Score: 92%
Study shows calcium and vitamin D supplements improve bone health
Internet Source, 11/09/09
Relevance Score: 89%
Evaluation of Compliance with Osteoporosis Treatment Guidelines After Initiation of a Pharmacist-Run Osteoporosis Service at a Family Medicine Clinic
Annals of Pharmacotherapy, 10/15/09
Relevance Score: 88%
BMD for all women at menopause
Internet Source, 10/07/09
Relevance Score: 88%
Today in Menopausal Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis
Journal of Bone and Mineral Metabolism, 12/03/09
A guide to lotions and potions for treating vaginal atrophy
OBG Management, 12/02/09
Bone loss or lost bone: Rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss
Current Osteoporosis Reports, 12/02/09
Sponsor
Article Search
Sponsor